Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
36 studies found for:    Guillain-Barré Syndrome
Show Display Options
Rank Status Study
1 Recruiting International Guillain-Barré Syndrome Outcome Study
Conditions: Guillain-Barré Syndrome;   Miller Fisher Syndrome
Intervention:
2 Completed Intravenous Immunoglobulin (IVIG) Versus Plasma Exchange (PE) for Ventilated Children With Guillain Barre Syndrome (GBS)
Condition: Guillain Barre Syndrome
Interventions: Drug: IVIG;   Procedure: Plasma Exchange
3 Recruiting sCD163 as a Potential Biomarker in Guillain- Barré Syndrome
Condition: Guillain-Barre Syndrome
Interventions: Procedure: Lumbar puncture;   Procedure: Blood Sample
4 Suspended Gastrointestinal Transit Time in Patients With Guillain-Barré Syndrome
Conditions: Guillain-Barre Syndrome;   Constipation
Intervention:
5 Completed Efficacy and Safety Study of GB-0998 for Guillain-Barré Syndrome
Condition: Guillain-Barré Syndrome
Intervention: Drug: GB-0998
6 Unknown  The Changes of Cytokines in Guillain Barré Syndrome: the Correlation With Clinical Manifestations and Skin Innervation
Condition: Guillain Barré Syndrome
Intervention:
7 Recruiting Small Volume Plasma Exchange (SVPE) for Guillain-Barré Syndrome (GBS) Patients
Condition: Guillain-Barré Syndrome
Intervention: Procedure: Small Volume Plasma Exchange
8 Unknown  Safety Study of GBS Following Menactra Meningococcal Vaccination
Condition: Guillain-Barre Syndrome
Intervention:
9 Completed Early Mechanical Ventilation for Guillain Barré Syndrome
Conditions: Guillain Barré Syndrome;   Acute Respiratory Failure
Interventions: Procedure: mechanical ventilation;   Procedure: physiotherapy and oxygen if needed
10 Completed Assessment of Chronic Guillain-Barre Syndrome Improvement With Use of 4-aminopyridine
Condition: Guillain-Barre Syndrome
Intervention: Drug: 4-aminopyridine (4-AP)
11 Terminated Randomized Study of Plasmapheresis or Human Immunoglobulin Infusion in Childhood Guillain-Barre Syndrome
Condition: Guillain-Barre Syndrome
Intervention: Drug: Immune globulin
12 Unknown  Phase III Clinical Trial of NPB-01 in Patients With Guillain-Barré Syndrome
Condition: Guillain-Barré Syndrome
Intervention: Drug: NPB-01
13 Completed Effects of Robotic-assisted Gait Training In Non-Ambulatory Patients After Guillain-Barré Syndrome
Condition: GBS
Interventions: Device: Robot-assisted Gait Training;   Other: conventional rehabilitation
14 Completed Prospective Study on Swallowing/Breathing Interactions in Severe Guillain Barre Syndrome.
Conditions: Tetraplegia;   Respiratory Failure
Intervention:
15 Unknown  Inhibition of Complement Activation (Eculizumab) in Guillain-Barre Syndrome Study
Condition: Gullian Barre Syndrome
Intervention: Drug: Eculizumab
16 Active, not recruiting JET-GBS - Japanese Eculizumab Trial for GBS
Condition: Gullain Barre Syndrome
Interventions: Drug: Eculizumab;   Drug: Placebo
17 Completed Brain Computer Interface for Communication in ICU: a Feasibility Study
Conditions: Tetraplegia;   Guillain-Barre Syndrome
Intervention:
18 Completed Regional Citrate Anticoagulation in Plasma Exchange Treatment
Conditions: Focal Segmental Glomerulosclerosis;   Guillain-Barre Syndrome
Intervention: Procedure: plasma exchange treatment
19 Unknown  Change of Nerve Conduction Properties in IVIg Dependent Neuropathies
Conditions: Guillain-Barre Syndrome;   CIDP;   Multifocal Motor Neuropathy
Intervention:
20 Completed Additional 6-Month Safety Follow-up After Completion of Precursor Study 880801
Condition: Prophylaxis of Ross River Virus Infection
Intervention: Biological: Ross River Virus (RRV) Vaccine

   Previous Page Studies Shown (1-20) Next Page (21-36) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.